Cleared Special

K170905 - Star Tissue Marker

K170905 is an FDA 510(k) clearance for Star Tissue Marker, manufactured by Scion Medical Technologies, LLC. The device is a Class 2 General & Plastic Surgery device with product code NEU cleared through the Special 510(k) pathway after a 30-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2017
Decision
30d
Days
Class 2
Risk

K170905 is an FDA 510(k) clearance for the Star Tissue Marker. Classified as Marker, Radiographic, Implantable (product code NEU), Class II - Special Controls.

Submitted by Scion Medical Technologies, LLC (Newtown Square, US). The FDA issued a Cleared decision on April 27, 2017 after a review of 30 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4300 - the FDA general and plastic surgery device framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Scion Medical Technologies, LLC devices

FDA 510(k) Submission Details - K170905

510(k) Number K170905 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2017
Decision Date April 27, 2017
Days to Decision 30 days
Submission Type Special
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
85d faster than avg
Panel avg: 115d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

NEU Device Classification - Class 2, Special Controls

Product Code NEU Marker, Radiographic, Implantable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 878.4300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - NEU Marker, Radiographic, Implantable

All 65
Devices cleared under the same product code (NEU) and FDA review panel - the closest regulatory comparables to K170905.
Tumark Vision
K180443 · Somatex Medical Technologies GmbH · Mar 2018
UltraCor Twirl Breast Tissue Marker
K180061 · Bard Peripheral Vascular, Inc. · Mar 2018
Magseed Magnetic Marker Systtem
K173587 · Endomagnetics Ltd., · Feb 2018
UltraCor Twirl Breast Tissue Marker
K152510 · Bard Peripheral Vascular, Inc. · May 2016
Beacon Fine Needle Fiducial System
K152586 · Covidien, LLC · Dec 2015
CAREFUSION GOLD TISSUE MARKER
K141722 · Care Fusion · Jan 2015